References

Cancer treatment and survivorship statistics, 2014 CA

10.3322/caac.21235 · 2014 · External reference

Radiotherapy for early-stage prostate cancer in men under 70 years of age

10.5301/tj.5000433 · 2015 · External reference

Pelvic radiotherapy and sexual function in men and women

10.1111/jsm.12010 · 2013 · External reference

Definitive radiotherapy for prostate cancer

10.1097/coc.0b013e31816d1ca6 · 2008 · External reference

Unresolved reference

2012 · External reference

The likely worldwide increase in erectile dysfunction between 1995 and 2025 and some possible policy consequences

10.1046/j.1464-410x.1999.00142.x · 1999 · External reference

Health-related quality of life of prostate cancer patients compared to the general German population: age-specific results

10.1159/000230018 · 2009 · External reference

The impact of sexual and urinary dysfunction on health-related quality-of-life (HRQOL) following radical prostatectomy (RP)

10.1038/sj.pcan.4500446 · 2000 · External reference

A historical review of erectile dysfunction

2003 · External reference

Vitex agnus castus as prophylaxis for osteopenia after orchidectomy in rats compared with estradiol and testosterone supplementation

10.1002/ptr.2711 · 2009 · External reference

Signalling through nuclear receptors

10.1038/nrm914 · 2002 · External reference

Mass spectrometry-based proteomics: Existing capabilities and future directions

10.1039/c2cs15331a · 2012 · External reference

Integrated proteo-genomic approach for early diagnosis and prognosis of cancer

10.1016/j.canlet.2015.08.003 · 2015 · External reference

Incorporating biologic measurements (SF(2), CFE) into a tumor control probability model increases their prognostic significance: A study in cervical carcinoma treated with radiation therapy

10.1016/s0360-3016(01)01584-x · 2001 · External reference

Overview radiosensitivity of human tumor cells to low dose rate irradiation

10.1016/j.ijrobp.2008.06.1928 · 2008 · External reference

Copy number variation in human health, disease, and evolution

10.1146/annurev.genom.9.081307.164217 · 2009 · External reference

Association between single nucleotide polymorphisms in the gene for XRCC1 and radiation-induced late toxicity in prostate cancer patients

10.1016/j.radonc.2011.01.021 · 2011 · External reference

Contrasting analytical and data-driven frameworks for radiogenomic modeling of normal tissue toxicities in prostate cancer

10.1016/j.radonc.2015.03.005 · 2015 · External reference

Mutations of gonadotropins and gonadotropin receptors: Elucidating the physiology and pathophysiology of pituitary-gonadal function

10.1210/edrv.21.5.0409 · 2000 · External reference

A 2-stage genome-wide association study to identify single nucleotide polymorphisms associated with development of urinary symptoms after radiotherapy for prostate cancer

10.1016/j.juro.2013.01.096 · 2013 · External reference

Treatment of radiation injury

10.1089/wound.2012.0403 · 2014 · External reference

The current progress and future prospects of personalized radiogenomic cancer study

10.7603/s40681-015-0002-0 · 2015 · External reference

Initial results of a phase 3 randomized study of high dose 3DCRT/IMRT versus standard dose 3D-CRT/IMRT in patients treated for localized prostate cancer (RTOG 0126)

10.1016/j.ijrobp.2014.10.035 · 2014 · External reference

Significant reduction of acute toxicity following pelvic irradiation with helical tomotherapy in patients with localized prostate cancer

10.1016/j.radonc.2007.07.013 · 2007 · External reference

Hypofractionated adjuvant radiotherapy with helical tomotherapy after radical prostatectomy: Planning data and toxicity results of a phase I-II study

10.1016/j.radonc.2008.03.021 · 2008 · External reference

Functional outcomes and complications following radiation therapy for prostate cancer: a critical analysis of the literature

10.1016/j.eururo.2011.09.027 · 2012 · External reference

Evaluating the relationship between erectile dysfunction and dose received by the penile bulb: Using data from a randomised controlled trial of conformal radiotherapy in prostate cancer (MRC RT01, ISRCTN47772397)

10.1016/j.radonc.2006.07.037 · 2006 · External reference

Sexual function after three-dimensional conformal radiotherapy for prostate cancer: Results from a dose-escalation trial

10.1016/j.ijrobp.2006.12.015 · 2007 · External reference

Penile bulb dose and impotence after 3-dimensional conformal radiotherapy for prostate cancer on RTOG 9406: Findings from a prospective, multi-institutional, phase I/II dose-escalation study

10.1016/j.ijrobp.2004.05.026 · 2004 · External reference

Preliminary patient-reported outcomes analysis of 3-dimensional radiation therapy versus intensity-modulated radiation therapy on the high-dose arm of the Radiation Therapy Oncology Group (RTOG) 0126 prostate cancer trial

10.1002/cncr.29362 · 2015 · External reference

Sexual, irritative, and voiding outcomes, following stereotactic body radiation therapy for prostate cancer

10.1186/s13014-015-0488-3 · 2015 · External reference

Image-guided Intensity-modulated radiotherapy for prostate cancer employing hypofractionation and simultaneous integrated boost: Results of a consecutive case series with focus on erectile function

2015 · External reference

12-year outcomes following permanent prostate brachytherapy in patients with clinically localized prostate cancer

2008 · External reference

Disease-specific survival following the brachytherapy management of prostate cancer

10.1016/j.ijrobp.2005.09.005 · 2006 · External reference

Effect of low dose-rate prostate brachytherapy on the sexual health of men with optimal sexual function before treatment: Analysis at ≥7 years of follow-up

10.1111/j.1464-410x.2007.07016.x · 2007 · External reference

Erectile function after prostate brachytherapy

10.1016/j.ijrobp.2004.10.001 · 2005 · External reference

Predictive factors for erectile dysfunction in men with prostate cancer after brachytherapy: Is dose to the penile bulb important?

10.1016/j.ijrobp.2004.12.056 · 2005 · External reference

Effect of aging and long-term erectile function after iodine-125 prostate brachytherapy

10.1016/j.brachy.2015.01.001 · 2015 · External reference

High-dose-rate monotherapy for localized prostate cancer: 10-year results

10.1016/j.ijrobp.2015.07.2290 · 2016 · External reference

10.1016/j.brachy.2010.02.127

10.1016/j.brachy.2010.02.127 · External reference

High-dose-rate interstitial brachytherapy as monotherapy for clinically localized prostate cancer: treatment evolution and mature results

10.1016/j.ijrobp.2012.07.004 · 2013 · External reference

Monotherapeutic high-dose-rate brachytherapy for prostate cancer: Five-year results of an extreme hypofractionation regimen with 54 Gy in nine fractions

10.1016/j.ijrobp.2010.02.013 · 2011 · External reference

High dose brachytherapy as monotherapy for intermediate risk prostate cancer

10.1016/j.juro.2011.09.050 · 2012 · External reference

High-dose-rate brachytherapy as a monotherapy for favorable-risk prostate cancer: A phase II trial

10.1016/j.ijrobp.2010.09.006 · 2012 · External reference

A report on the clinical outcome after high-dose rate (HDR) brachytherapy as monotherapy in early prostate cancer

2015 · External reference

High-dose-rate brachytherapy as monotherapy for prostate cancer

2014 · External reference

Erectile function, incontinence, and other quality of life outcomes following proton therapy for prostate cancer in men 60 years old and younger

10.1002/cncr.27398 · 2012 · External reference

The proton beam debate: are facilities outstripping the evidence?

10.1093/jnci/djq112 · 2010 · External reference

StatBite: Particle beam therapy facilities worldwide

2010 · External reference

The Titanic and the iceberg: Prostate proton therapy and health care economics

10.1200/jco.2007.11.9768 · 2007 · External reference

Radiotherapy treatment of early-stage prostate cancer with IMRT and protons: A treatment planning comparison

10.1016/j.ijrobp.2007.03.018 · 2007 · External reference

Protons and parachutes

10.1200/jco.2008.17.1165 · 2008 · External reference

Microvascular dysfunction and efficacy of PDE5 inhibitors in BPH-LUTS

10.1038/nrurol.2014.53 · 2014 · External reference

A randomised, double-blind, placebo-controlled trial of nightly sildenafil citrate to preserve erectile function after radiation treatment for prostate cancer

10.1111/j.1754-9485.2012.02461.x · 2013 · External reference

Prophylactic sildenafil citrate improves select aspects of sexual function in men treated with radiotherapy for prostate cancer

10.1016/j.juro.2014.02.097 · 2014 · External reference

Role of oxidative stress in a rat model of radiation-induced erectile dysfunction

10.1111/j.1743-6109.2012.02716.x · 2012 · External reference

Radiation-induced erectile dysfunction using prostate-confined modern radiotherapy in a rat model

10.1111/j.1743-6109.2011.02351.x · 2011 · External reference

Feasibility study of an intensity-modulated radiation model for the study of erectile dysfunction

10.1111/j.1743-6109.2010.02125.x · 2011 · External reference

Pilot study evaluating a rat model of radiation-induced erectile dysfunction using an image-guided microirradiator

10.1016/j.urology.2014.12.020 · 2015 · External reference

Erectile dysfunction after radiotherapy for prostate cancer and radiation dose to the penile structures: A critical review

10.1016/j.radonc.2007.07.018 · 2007 · External reference

The antioxidant, MnTE-2-PyP, prevents side-effects incurred by prostate cancer irradiation

10.1371/journal.pone.0044178 · 2012 · External reference

Radiation-associated impotence. A clinical study of its mechanism

10.1001/jama.1984.03340310017012 · 1984 · External reference

A study of penile circulation before and after radiation in patients with prostate cancer and its effect on impotence

10.1016/0360-3016(85)90059-8 · 1985 · External reference

Pudendal nerve and internal pudendal artery damage may contribute to radiation-induced erectile dysfunction

10.1016/j.ijrobp.2014.12.025 · 2015 · External reference

Effects of intravenous injection of adipose-derived stem cells in a rat model of radiation therapy-induced erectile dysfunction

10.1111/j.1743-6109.2012.02753.x · 2012 · External reference

Recruitment of intracavernously injected adipose-derived stem cells to the major pelvic ganglion improves erectile function in a rat model of cavernous nerve injury

10.1016/j.eururo.2011.07.061 · 2012 · External reference

Both immediate and delayed intracavernous injection of autologous adipose-derived stromal vascular fraction enhances recovery of erectile function in a rat model of cavernous nerve injury

10.1016/j.eururo.2012.02.003 · 2012 · External reference

Separate or combined treatments with daily sildenafil, molsidomine, or muscle derived stem cells prevent erectile dysfunction in a rat model of cavernosal nerve damage

10.1111/j.1743-6109.2012.02913.x · 2012 · External reference

Stem-cell therapy for erectile dysfunction

10.1517/14712598.2013.847085 · 2013 · External reference

Evaluation of clinical efficacy, safety and patient satisfaction rate after low-intensity extracorporeal shockwave therapy for the treatment of male erectile dysfunction: An Australian first open-label single-arm prospective clinical trial

10.1111/bju.13035 · 2015 · External reference

Shockwave treatment of erectile dysfunction

10.1177/1756287212470696 · 2013 · External reference

Extracorporeal shockwave therapy in the treatment of erectile dysfunction: A prospective, randomized, double-blinded, placebo controlled study

10.1111/iju.12506 · 2014 · External reference

NIH and USDA funding of dietary supplement research, 1999-2007

10.3945/jn.110.134106 · 2011 · External reference

A urologist's guide to ingredients found in top-selling nutraceuticals for men's sexual health

10.1111/jsm.13013 · 2015 · External reference

Safety and quality assessment of 175 illegal sexual enhancement products seized in red-light districts in Singapore

10.2165/11316690-000000000-00000 · 2009 · External reference

Effects of Korean ginseng berry extract (GB0710) on penile erection: Evidence from in vitro and in vivo studies

10.1038/aja.2013.49 · 2013 · External reference

An experimental study of the effect of ginkgobiloba extract on the human and rabbit corpus cavernosumtissue

10.1016/s0022-5347(01)65557-5 · 1996 · External reference

Protective effects of nutritional supplementation with arginine and glutamine on the penis of rats submitted to pelvic radiation

10.1111/andr.134 · 2014 · External reference

Cavernous nerve regeneration using acellular nerve grafts

10.1007/s00345-008-0283-y · 2008 · External reference

Bioengineered corporal tissue for structural and functional restoration of the penis

10.1073/pnas.0909367106 · 2010 · External reference

New advances in erectile technology

10.1177/1756287213505670 · 2014 · External reference